Effects of glycyrrhizin on biliary transport and hepatic levels of glutathione in rats

Biopharmaceutics and Drug Disposition

Volumn 33, Issue 5, 2012, Pages 235-245

  Xu, Ruijuan ^a   Zhang, Xueying ^a   Yang, Jin ^a   Liu, Xiaoquan ^a   Davey, Andrew K ^b   Wang, Jiping ^c  

^a CHINA PHARMACEUTICAL UNIVERSITY   (China)

^b GRIFFITH UNIVERSITY   (Australia)

^c UNIVERSITY OF SOUTH AUSTRALIA   (Australia)

Author keywords

glutathione; glycyrrhizin; isolated liver perfusion; membrane vesicles; multidrug resistance associated transporters

Indexed keywords

ADENOSINE TRIPHOSPHATE; ESTRADIOL 17 GLUCURONIDE; GLUTATHIONE; GLYCYRRHIZIC ACID; METHOTREXATE; MULTIDRUG RESISTANCE PROTEIN 2;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BILE FLOW; BILE SECRETION; CONTINUOUS INFUSION; CONTROLLED STUDY; LIVER PERFUSION; LOADING DRUG DOSE; MALE; MEMBRANE VESICLE; NONHUMAN; RAT;

ANIMALS; ANTI-INFLAMMATORY AGENTS; BILE; BILIARY TRACT; BIOLOGICAL TRANSPORT, ACTIVE; DOSE-RESPONSE RELATIONSHIP, DRUG; ESTRADIOL; GLUTATHIONE; GLYCYRRHIZIC ACID; LIVER; MALE; METHOTREXATE; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; PERFUSION; RATS; RATS, SPRAGUE-DAWLEY; SUBSTRATE SPECIFICITY;

EID: 84863717489     PISSN: 01422782     EISSN: 1099081X     Source Type: Journal    
DOI: 10.1002/bdd.1789     Document Type: Article

References (35)

1. Missiha SB, Ostrowski M, Heathcote EJ,. Disease progression in chronic hepatitis C: modifiable and nonmodifiable factors. Gastroenterology 2008; 134: 1699-1714. (Pubitemid 351615412)
2. Shibata S,. A drug over the millennia: pharmacognosy, chemistry, and pharmacology of licorice. Yakugaku Zasshi 2000; 120: 849-862.
3. Stickel F, Schuppan D,. Herbal medicine in the treatment of liver diseases. Dig Liver Dis 2007; 39: 293-304. (Pubitemid 46432239)
4. Nakamura T, Fujii T, Ichihara A,. Enzyme leakage due to change of membrane permeability of primary cultured rat hepatocytes treated with various hepatotoxins and its prevention by glycyrrhizin. Cell Biol Toxicol 1985; 1: 285-295. (Pubitemid 16257883)
5. Melhem A, Stern M, Shibolet O, et al,. Treatment of chronic hepatitis C virus infection via antioxidants: results of a phase I clinical trial. J Clin Gastroenterol 2005; 39: 737-742. (Pubitemid 41177097)
6. Vidali M, Tripodi MF, Ivaldi A, et al,. Interplay between oxidative stress and hepatic steatosis in the progression of chronic hepatitis C. J Hepatol 2008; 48: 399-406.
7. Balendiran GK, Dabur R, Fraser D,. The role of glutathione in cancer. Cell Biochem Funct 2004; 22: 343-352. (Pubitemid 39518098)
8. Nagai T, Egashira T, Kudo Y, et al,. Attenuation of dysfunction in the ischemia-reperfused liver by glycyrrhizin. Jpn J Pharmacol 1992; 58: 209-218.
9. Lee CH, Park SW, Kim YS, et al,. Protective mechanism of glycyrrhizin on acute liver injury induced by carbon tetrachloride in mice. Biol Pharm Bull 2007; 30: 1898-1904. (Pubitemid 47607779)
10. Yang J, Zhou L, Wang J, et al,. The disposition of diammonium glycyrrhizinate and glycyrrhetinic acid in the isolated perfused rat intestine and liver. Planta Med 2008; 74: 1351-1356.
11. Konig J, Nies AT, Cui Y, et al,. Conjugate export pumps of the multidrug resistance protein (MRP) family: localization, substrate specificity, and MRP2-mediated drug resistance. Biochim Biophys Acta 1999; 1461: 377-394.
12. Liang XJ, Aszalos A,. Multidrug transporters as drug targets. Curr Drug Targets 2006; 7: 911-921. (Pubitemid 44227577)
13. Masuda M, I'Izuka Y, Yamazaki M, et al,. Methotrexate is excreted into the bile by canalicular multispecific organic anion transporter in rats. Cancer Res 1997; 57: 3506-3510. (Pubitemid 27355499)
14. Morikawa A, Goto Y, Suzuki H, et al,. Biliary excretion of 17beta-estradiol 17beta-D-glucuronide is predominantly mediated by cMOAT/MRP2. Pharm Res 2000; 17: 546-552. (Pubitemid 30416392)
15. Sun H, Zeng YY, Pang KS,. Interplay of phase II enzymes and transporters in futile cycling: influence of multidrug resistance-associated protein 2-mediated excretion of estradiol 17beta-D-glucuronide and its 3-sulfate metabolite on net sulfation in perfused TR(-) and Wistar rat liver preparations. Drug Metab Dispos 2010; 38: 769-780.
16. Shimamura H, Suzuki H, Tagaya O, et al,. Biliary excretion of glycyrrhizin in rats: kinetic basis for multiplicity in bile canalicular transport of organic anions. Pharm Res 1996; 13: 1833-1837. (Pubitemid 27034115)
17. Horikawa M, Kato Y, Tyson CA, Sugiyama Y,. The potential for an interaction between MRP2 (ABCC2) and various therapeutic agents: probenecid as a candidate inhibitor of the biliary excretion of irinotecan metabolites. Drug Metab Pharmacokinet 2002; 17: 23-33.
18. Griffith OW,. Determination of glutathione and glutathione disulfide using glutathione reductase and 2-vinylpyridine. Anal Biochem 1980; 106: 207-212. (Pubitemid 11246585)
19. Mashige F, Tanaka N, Maki A, et al,. Direct spectrophotometry of total bile acids in serum. Clin Chem 1981; 27: 1352-1356. (Pubitemid 11041570)
20. Mori L,. Modified Jendrassik-Grof method for bilirubins adapted to the Abbott bichromatic analyzer. Clin Chem 1978; 24: 1841-1845. (Pubitemid 9028285)
21. Franco R, Schoneveld OJ, Pappa A, Panayiotidis MI,. The central role of glutathione in the pathophysiology of human diseases. Arch Physiol Biochem 2007; 113: 234-258.
22. Wu YT, Shen C, Yin J, et al,. Azathioprine hepatotoxicity and the protective effect of liquorice and glycyrrhizic acid. Phytother Res 2006; 20: 640-645.
23. Marchan R, Hammond CL, Ballatori N,. Multidrug resistance-associated protein 1 as a major mediator of basal and apoptotic glutathione release. Biochim Biophys Acta 2008; 1778: 2413-2420.
24. Lai L, Tan TM,. Role of glutathione in the multidrug resistance protein 4 (MRP4/ABCC4)-mediated efflux of cAMP and resistance to purine analogues. Biochem J 2002; 361: 497-503. (Pubitemid 34177819)
25. Wijnholds J, Mol CA, van Deemter L, et al,. Multidrug-resistance protein 5 is a multispecific organic anion transporter able to transport nucleotide analogs. Proc Natl Acad Sci USA 2000; 97: 7476-7481. (Pubitemid 30431488)
26. Ito K, Suzuki H, Hirohashi T, et al,. Molecular cloning of canalicular multispecific organic anion transporter defective in EHBR. Am J Physiol 1997; 272: G16-G22.
27. Abbott WA, Meister A,. Intrahepatic transport and utilization of biliary glutathione and its metabolites. Proc Natl Acad Sci USA 1986; 83: 1246-1250. (Pubitemid 16016105)
28. Zsembery A, Thalhammer T, Graf J,. Bile formation: a concerted action of membrane transporters in hepatocytes and cholangiocytes. News Physiol Sci 2000; 15: 6-11.
29. Nathanson MH, Boyer JL,. Mechanisms and regulation of bile secretion. Hepatology 1991; 14: 551-566.
30. Ballatori N, Truong AT,. Glutathione as a primary osmotic driving force in hepatic bile formation. Am J Physiol 1992; 263: G617-G624.
31. Ichikawa T, Ishida S, Sakiya Y, et al,. Biliary excretion and enterohepatic cycling of glycyrrhizin in rats. J Pharm Sci 1986; 75: 672-675. (Pubitemid 16038897)
32. Cantelli-Forti G, Raggi MA, Bugamelli F, et al,. Toxicological assessment of liquorice: biliary excretion in rats. Pharmacol Res 1997; 35: 463-470. (Pubitemid 27387269)
33. van Rossum TG, Vulto AG, Hop WC, Schalm SW,. Pharmacokinetics of intravenous glycyrrhizin after single and multiple doses in patients with chronic hepatitis C infection. Clin Ther 1999; 21: 2080-2090. (Pubitemid 30043923)
34. Wakamatsu T, Nakahashi Y, Hachimine D, et al,. The combination of glycyrrhizin and lamivudine can reverse the cisplatin resistance in hepatocellular carcinoma cells through inhibition of multidrug resistance-associated proteins. Int J Oncol 2007; 31: 1465-1472.
35. Paulusma CC, van Geer MA, Evers R, et al,. Canalicular multispecific organic anion transporter/multidrug resistance protein 2 mediates low-affinity transport of reduced glutathione. Biochem J 1999; 338: 393-401.